- Home
- MRSN vs ICMB Comparison
MRSN vs ICMB Comparison
Compare MRSN & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- ICMB
- Stock Information
- Founded
- MRSN 2001
- ICMB 2012
- Country
- MRSN United States
- ICMB United States
- Employees
- MRSN N/A
- ICMB N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- MRSN Health Care
- ICMB Finance
- Exchange
- MRSN Nasdaq
- ICMB Nasdaq
- Market Cap
- MRSN 37.0M
- ICMB 40.6M
- IPO Year
- MRSN 2017
- ICMB N/A
- Fundamental
- Price
- MRSN $7.24
- ICMB $2.73
- Analyst Decision
- MRSN Strong Buy
- ICMB
- Analyst Count
- MRSN 4
- ICMB 0
- Target Price
- MRSN $63.67
- ICMB N/A
- AVG Volume (30 Days)
- MRSN 138.9K
- ICMB 24.9K
- Earning Date
- MRSN 08-13-2025
- ICMB 08-12-2025
- Dividend Yield
- MRSN N/A
- ICMB 17.45%
- EPS Growth
- MRSN N/A
- ICMB N/A
- EPS
- MRSN N/A
- ICMB 0.93
- Revenue
- MRSN $34,769,000.00
- ICMB $20,422,069.00
- Revenue This Year
- MRSN N/A
- ICMB N/A
- Revenue Next Year
- MRSN $1.03
- ICMB N/A
- P/E Ratio
- MRSN N/A
- ICMB $2.96
- Revenue Growth
- MRSN 16.14
- ICMB N/A
- 52 Week Low
- MRSN $5.21
- ICMB $2.46
- 52 Week High
- MRSN $70.75
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- MRSN 48.99
- ICMB 44.08
- Support Level
- MRSN $5.21
- ICMB $2.60
- Resistance Level
- MRSN $7.68
- ICMB $2.71
- Average True Range (ATR)
- MRSN 0.54
- ICMB 0.09
- MACD
- MRSN 0.12
- ICMB -0.00
- Stochastic Oscillator
- MRSN 81.04
- ICMB 54.05
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.